SKYRIZI is indicated for the treatment of adult patients with moderately to severely active Crohnʼs disease who have had an inadequate response to, lost response to, or were intolerant to conventional therapy or a biologic therapy.1
PATIENT RESOURCES DESIGNED TO SUPPORT YOUR PATIENTS DURING THEIR CD TREATMENT
Resources for your patients prescribed SKYRIZI, designed with input from patients living with Crohnʼs disease (CD) and healthcare professionals like you.
Supporting your patients at each step of the treatment journey
While every patient is different, these patient resources aim to support your patients at each phase of the SKYRIZI treatment plan you have prescribed.
Induction
Transition
Maintenance
Induction
Transition
Maintenance
Induction
Materials in this phase aim to leverage the patientʼs time in the infusion chair and help them understand their treatment plan. These materials include:
Welcome to SKYRIZI Booklet
As a supplement to the Patient Information Leaflet, download this patient starter booklet to help educate and engage patients with their prescribed treatment plan. Topics include how SKYRIZI works, what to expect from treatment with SKYRIZI, FAQs, and more.
Your Treatment and On-Body Injection Device Video
This video explains the patientʼs condition, overview of their treatment plan, and how it will help them manage their symptoms.
Understanding Your Infusions Video
This video provides detailed information about the infusion process and experience for the patientʼs first three IV doses in clinic, what to expect, and how to prepare.
Patient Information Leaflet
This resource, which is also included in the medication packaging, will provide patients with detailed information about SKYRIZI.
Affiliates to include per your local regulations
Transition
Materials in this phase aim to introduce your patients to the on-body injector (OBI) and help them understand how to self-inject with their OBI (at home). These materials include:
Moving From Infusions to the OBI Video
This video informs patients on everything they need to do to be prepared for their first OBI injection.
In-clinic, Reusable OBI Demonstration Kit Training Device
The demonstration kit is intended to be used by HCPs to help teach patients how to use the OBI. Ask your sales representative to deliver a kit to your office.
Training With the OBI Demonstration Kit Video
This video introduces patients to the OBI demonstration device their HCP will use for in-office training.
Patient Information Leaflet
This resource, which is also included in the medication packaging, will provide patients with detailed information about SKYRIZI.
Affiliates to include per your local regulations
Maintenance
Materials in this phase aim to build your patientsʼ confidence with the OBI device. They intend to support patients during their at-home self-injection treatment, including troubleshooting tips and contact information. These materials include:
Step-by-Step OBI Injection Video
This video provides patients with everything they need to prepare for each OBI injection. It includes a description of each part of the OBI along with injection steps based on the approved OBI Instructions for Use.
OBI Instructions for Use
Download the OBI patient Instructions for Use for detailed information on when and how to administer the maintenance injections.
Affiliates to include per your local regulations
OBI Executive Summary
Download the OBI 360 Executive Summary for an introduction to the OBI, including highlights on the most important information to supplement the Instructions for Use. Also included are quick tips, troubleshooting guides, and signposts to other available resources.
Welcome to the Maintenance Phase Quick Reference Sheet
Download this 1-page reference guide as a supplement to the complete Patient Information Leaflet and Instructions for Use. It provides quick tips on how to use the OBI and includes a QR code to link to additional resources.
Patient Information Leaflet
This resource, which is also included in the medication packaging, will provide patients with detailed information about SKYRIZI.
Affiliates to include per your local regulations
Find information about AbbVie Care and how to enroll your patients
Indication1
SKYRIZI is indicated for the treatment of adult patients with moderately to severely active Crohnʼs disease who have had an inadequate response to, lost response to, or were intolerant to conventional therapy or a biologic therapy.
Important Safety Information1
Affiliate to insert local ISI.
Reference: 1. SKYRIZI [Summary of Product Characteristics]. Ludwigshafen, Germany: AbbVie Deutschland GmbH & Co; January 2024.